Paul B. Manning - Nov 24, 2021 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director, 10%+ Owner
Signature
/s/ Kamran Alam, Attorney-in-Fact
Stock symbol
TSHA
Transactions as of
Nov 24, 2021
Transactions value $
$29,044
Form type
4
Date filed
11/29/2021, 04:01 PM
Previous filing
Nov 24, 2021
Next filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $29K +2.2K +6.88% $13.19* 34.2K Nov 24, 2021 Direct F1, F2
holding TSHA Common Stock 3.2M Nov 24, 2021 See footnote F3
holding TSHA Common Stock 2.02M Nov 24, 2021 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.115 to $13.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Shares held by Mr. Manning jointly with his spouse.
F3 The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.
F4 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.